Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up

Transplant Proc. 2002 Aug;34(5):1638-9. doi: 10.1016/s0041-1345(02)02961-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Azathioprine / therapeutic use*
  • Diabetes Mellitus, Type 1 / epidemiology
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology*
  • Leukopenia / chemically induced
  • Leukopenia / epidemiology
  • Middle Aged
  • Postoperative Complications / classification
  • Postoperative Complications / epidemiology*
  • Spain
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Azathioprine
  • Tacrolimus